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Abstract— Humans are exposed to Bisphenol A (BPA) 
contaminated packaged drinking water, foods and beverages. 
The effects of BPA on the function of intestinal smooth muscle 
and cardiac myocytes have been examined in this study. The 
record of the movements of isolated intestine and perfused heart 
of toad in response to single dose acute exposure of BPA have 
been recorded with isotonic transducer coupled to the RMS 
Polyrite-D. We found significant depression of the movement of 
duodenum and heart in a dose dependent manner. Further, it 
was observed that sodium nitroprusside (SNP), a nitric oxide 
(NO) donor, significantly potentiated the BPA induced inhibition 
of duodenal and cardiac movement. However, methylene blue 
(MB), a guanylyl cycalse (GC) inhibitor, and Nω-nitro-L-arginine 
methyl ester hydrochloride (L-NAME), a nitric oxide synthase 
(NOS) inhibitor, significantly counteracted the BPA induced 
inhibition of duodenal and cardiac movement. Thus, we may 
conclude that BPA depresses the duodenal and cardiac 
movement through NO-mediated GC signal pathway.     
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I.  INTRODUCTION  
Bisphenol A (BPA) is a man-made organic compound with 
two phenol functional groups. It is the building block of 
several plastics and plastic additives. The commercial use of 
the monomeric form of BPA in the production of 
polycarbonate plastics and epoxy resins [1-6] and as a non-
polymer additive to other plastics [7,8] is increasing 
enormously. Polycarbonate plastics due to its clarity and 
toughness has been in use to make various types of products 
like water bottles, baby feeding bottles, soft and hard drink 
containers etc. Besides, BPA is widely used to manufacture 
other plastic products like- eyeglass lenses, medical 
equipments, CDs, DVDs, electrical equipments, sports safety 
equipments and many more household appliances. Epoxy 
resin is used for lining metal cans to maintain quality of 
canned food and beverages due to its chemical resistance. 
However, recent studies have revealed that BPA leaches from 
the protective internal epoxy resin coatings of canned foods 
and from consumer plastic products into the food contents 
[9,10]. The degree of leaching of BPA from polycarbonate 
bottles into its content has been found to depend more on the 
temperature of the liquid or bottle, than the age of the 
container. Repeated washing of the bottle with harsh detergent 
also enhances the leaching process [11].  
 
Widespread and continuous human exposure to BPA occurs 
mainly through dietary intake [12], with additional exposure 
through dental sealant, dermal exposure and inhalation of 
indoor and outdoor dusts [13-15]. It exerts multi-system 
toxicity in animal models. The mode of action of BPA appears 
to mimic that of the female hormone estrogen. Therefore, BPA 
can be said as a man made endocrine disrupting chemical. 
 
Moreover, it has been reported that BPA alters the function of 
coronary smooth muscle by activating Maxi-K (KCa.1.1) 
channels [16]. Besides, the studies of Pant J and associates 
have revealed that BPA causes depression of the atrial 
contractility in rat through NO-dependent guanylyl cyclase 
signaling pathway [17]. Further the study of Liang Q et. al. 
reported that BPA progressively increase sarcoplasmic 
reticulum (SR) Ca2+ release and Ca2+ reuptake and inhibit the 
L-type Ca2+ current (Ical) in cardiac myocytes [18]. But, there 
is lack of information regarding the effect of BPA on the 
movement of heart in animal models.  
 
However, it has already been reported that the gastrointestinal 
mucosae are directly exposed to BPA. But, the effect of BPA 
on the gastrointestinal motility has not been studied till to date. 
The gastrointestinal motility causes the movements of ingested 
food stuffs from stomach to intestine for digestion in systemic 
order and absorption of digested food stuffs from intestine to 
the intestinal blood vessels and lymphatic ducts. The principal 
motor of the intestinal wall is the smooth muscle, arranged 
circularly and longitudinally, in the muscular layer of the 
intestinal wall. The motor functions of the smooth muscle are 
locally controlled by Myenteric (Auerbach’s) plexus, and 
centrally by sympathetic and parasympathetic efferent fibres 
that innervates the Myenteric central neural pool. In that case, 
there may be a chance of occurrence of BPA induced toxicity 
in intestinal motor function.  
Therefore, the aim of the present study has been designed to 
examine the effect of BPA on the motor function of intestine 
and the movement of heart in animal models. Motor function 
of intestine and heart are mainly controlled by cholinergic, 
adrenergic and non-adrenergic non-cholinergic (NANC) 
pathways. Here, we only focused on the NANC mechanism in 
the control of smooth muscle and cardiac muscle function.  
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II. MATERIALS AND METHODS 
A. Reagents and chemicals 
All the common chemicals used for this study were of 
analytical grade. Bisphenol a (BPA ≥99%), Nω-nitro-L-
arginine methyl ester hydrochloride (L-NAME) were 
purchased from sigma chemicals co. (USA). Dimethyl 
sulfoxide (DMSO), sodium chloride (NaCl), potassium 
chloride (KCl), magnesium chloride (MgCl2), calcium 
chloride (CaCl2), sodium bicarbonate (NaHCO3), sodium 
dihydrogen phosphate (NaH2PO4), sodium nitroprusside 
(SNP), methylene blue (MB) etc. were procured from EMerck, 
India.  
B. Animal used for this study 
Studies were carried out on 14-16 weeks old White Albino 
rats of the Sprague Dawley Strain weighing about 110-150 gm 
(for study of motor function of intestine) and adult male 
common Indian Toads (Duttaphrynus melanostictus) (for 
study of motor function of heart). Animals were maintained in 
Animal House as per recommendations of the Kalyani 
University Animal Ethics Committee.  In the experimental set 
up, toad’s heart was perfused to study the effects of intended 
drugs (BPA) on the motor function of heart in vivo in 
anaesthetized toad. Because, the perfusion set up in rat is very 
difficult due to non-sustainability of heart movement in 
perfused state for a long period required for the experiment 
under anesthesia. 
 
C. Recording of intsetinal movement 
For study of intestinal motility the rats were sacrificed by 
cervical dislocation after overnight fasting conditions; the 
abdomen was immediately opened and the duodenal segments 
(3cm each) were removed by transverse incision and were 
used for recording of intestinal motility according to our 
standard laboratory protocol. After removing the duodenal 
segments it was placed in Tyrode’s solution consisting of 8.0 
g/l NaCl, 0.2 g/l KCl, 0.2 g/l CaCl2, 0.1 g/l MgCl2, 1.0 g/l 
NaHCO3, 0.05 g/l NaH2PO4 and 1.0 g/l Glucose (pH 7.4). The 
luminal content of each segment was gently flushed out. Then 
the duodenal part was placed longitudinally in 40ml organ 
bath containing Tyrode’s solution and continuously bubbled 
with 95 % O2 and 5% CO2, and temperature was maintained 
within a range of 37ºC ± 0.5. Therefore, continuous recording 
of duodenal movement was achieved with isotonic transducer 
(IT-2245) coupled to RMS-Polyrite-D (RMS, Chandigarh, 
India). 
D. Perfusion method of toad heart 
The acute study was performed on perfused heart of toad 
according to our standard laboratory protocol. After the 
anesthetization of toad by pithing, the heart was perfused with 
the toad Ringer’s solution (NaCl- 0.65gm%, KCl- 0.014gm%, 
CaCl2- 0.012gm%, NaHCO3- 0.02gm%, NaH2PO4-0.001gm%, 
Dextrose-0.2gm%, pH 7.4). The apex of the ventricle was 
hooked at one end of the transducer. The recording was taken 
in the monitor fitted with the RMS polyrite-D machine.  
E. Experimental design 
The experimental set up for this study is given below- 
Set 1-A Application of graded doses of BPA (10, 20, 40µM) on 
duodenal segments. 
Set-1-B Application of equivalent doses of DMSO (2, 4, 8 µM) on 
duodenal segments.* 
Set-1-C Application of doses of BPA on duodenal segments pre-
treated with SNP (3.3µM for 5mins), MB (200µM for 
10mins) and L-NAME (180µM for 10mins). 
Set-2-A Application of graded doses of BPA (10, 20, 40µM) on 
perfused heart of toad. 
Set-2-B Application of equivalent doses of DMSO (2, 4, 8 µM) on 
perfused heart of toad.* 
Set-2-C Application of doses of BPA on perfused heart of toad pre-
applied with SNP (3.3µM for 5mins), MB (200µM for 
10mins) and L-NAME (180µM for 10mins). 
* DMSO was used as solvent of BPA in this study.  
 
F. Statistical analysis 
The data were expressed as mean± SEM of the value of each 
experimental group. Force of contractions of duodenal and 
cardiac movements were measured in terms of amplitude and 
frequency. For analysis, the values of the treated preparations 
were expressed as percent change of the basal (or control) 
values. Statistical comparisons between the values obtained in 
control and in treated rats were carried out by using ANOVA 
followed by Student’s t-test. p≤0.05 was considered 
statistically significant.  
III. RESULTS 
A. Effect of BPA on duodenal and cardiac movement of 
animals 
After the application of graded doses of BPA (10-40µM) on 
duodenal segments (n=7) and perfused heart of toad (n=7), it 
has been observed that BPA dose dependently depresses the 
duodenal and cardiac movement significantly in terms of 
amplitude and frequency of contractions (Fig. 1 & Fig.2).  
 
Figure 1: Representative records of movements of duodenum and heart after 
the application of graded doses of BPA. Panel A: Records of movement of 
isolated duodenum of rat after the application of DMSO and BPA. Panel B:  
Records of movement of perfused heart of toad after the application of DMSO 
and BPA. 
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Figure 2: Showing the percent changes in amplitude and frequency of 
movement of duodenum and heart after application of graded doses of BPA. 
A & C: Percent changes in amplitude of movement of duodenum and heart 
after application of graded doses of BPA. B & D: Percent changes in 
frequency of movement of duodenum and heart after application of graded 
doses of BPA. Data were expressed as mean±SEM, n=7; *p<0.05 vs. vehicle 
control (DMSO). 
 
B. Effect of BPA on duodenal segments and perfused heart of 
toad pre-applied with SNP 
From the results it was observed that SNP (n=5) significantly 
potentiated the BPA induced inhibition of duodenal and 
cardiac movement compared to BPA alone. Whereas, 
application of SNP alone initially depresses the movement 
slightly but the movement returns to the resting level after 2 
minutes (Fig. 3 & Fig.4).  
 
 
Figure 3: Representative records of the effects of BPA on movements of 
duodenum and heart after the application of SNP. Panel A: Records of the 
movement of duodenum. Panel B: Records of the movement of heart.   
 
Figure 4: Showing the effect of BPA on isolated duodenum and perfused 
heart of toad when applied after the application of SNP. A & C: Percent 
changes in amplitude of movement of duodenum and heart after the 
application of graded doses of BPA pre-applied with SNP. B & D: Percent 
changes in frequency of movement of duodenum and heart after the 
application of graded doses of BPA pre-applied with SNP. Data were 
expressed as mean±SEM, n=7; ap<0.05 vs. SNP; bp<0.05 vs. BPA. 
 
C. Effect of BPA on duodenal segments and perfused heart of 
toad pre-applied with MB 
It has been observed that the application of the same dose of 
SNP in MB (the guanylyl cyclase inhibitor) pre-applied 
duodenal and cardiac preparations did not produce any 
significant inhibition of the movement. But the application of 
BPA in MB pre-incubated preparations (200µM for 10 
minutes) produced inhibition of the movement immediately 
after the application, but the movement of duodenum and 
heart were reversed significantly towards the resting level 
after 15minutes of the application of BPA (Fig. 5 & Fig.7). 
Further, it was observed that the MB alone initially increases 
the duodenal and cardiac movement but the movement 
returned to the resting level after 1minute.   
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Figure 5: Showing the effect of BPA on isolated duodenum and perfused 
heart of toad when applied after the application of MB. A & C: Percent 
changes in amplitude of movement of duodenum and heart after the 
application of graded doses of BPA pre-applied with MB. B & D: Percent 
changes in frequency of movement of duodenum and heart after the 
application of graded doses of BPA pre-applied with MB. Data were 
expressed as mean±SEM, n=7; ap<0.05 vs. MB; bp<0.05 vs. BPA. 
 
D. Effect of BPA on duodenal segments and perfused heart of 
toad pre-applied with L-NAME 
In order to confirm the involvement of NO pathway in BPA 
induced inhibition of duodenal and cardiac movements, the 
doses of BPA were applied after the application of L-NAME 
(the NOS inhibitor) on duodenal and cardiac preparations. It 
has been observed that the application of L-NAME (180 µM) 
does not produce any significant changes in duodenal and 
cardiac movements. Further, the application of BPA in L-
NAME pre-applied preparations (180µM for 10 minutes), the 
duodenal and cardiac movement were reversed significantly 
towards the resting level after 20minutes of the application of 
BPA (Fig.6 & Fig.7) compared to the movement obtained 
after the application of BPA alone.  
 
Figure 6: Showing the effect of BPA on isolated duodenum and perfused 
heart of toad when applied after the application of L-NAME. A & C: Percent 
changes in amplitude of movement of duodenum and heart after the 
application of graded doses of BPA pre-applied with L-NAME. B & D: 
Percent changes in frequency of movement of duodenum and heart after the 
application of graded doses of BPA pre-applied with L-NAME. Data were 
expressed as mean±SEM, n=7; ap<0.05 vs. L-NAME; bp<0.05 vs. BPA. 
 
 
 
Figure 7: Representative records of the effects of BPA on movements of 
duodenum and heart after the application of MB and L-NAME. Panel A: 
Records of the movement of duodenum. Panel B: Records of the movement of 
heart.   
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IV. DISCUSSION 
From this study it has been observed that BPA dose 
dependently depresses the duodenal and cardiac movement. 
Results obtained from the study implies that NO is involved in 
the BPA induced inhibition of duodenal and cardiac 
movement. It has been studied that the neuronally generated 
NO diffuses to smooth and cardiac muscle cells which contain 
soluble guanylyl cyclase (sGC). sGC is an important NO-
sensitive mediator in the signal transduction of smooth and 
cardiac muscle relaxation. The activated sGC catalyzes the 
conversion of GTP to cyclic GMP (cGMP), which in turn 
activates the cGMP-dependent protein kinase G (PKG). PKG 
subsequently stimulates the extrusion of intracellular Ca2+ by 
phosphorylating a number of important target proteins 
including ion channels, ion pumps, receptors and enzymes; 
thereby decreases the sensitivity of contractile apparatus to 
Ca2+ which leads to the muscle relaxation [19-25]. In this 
study, it has been observed that MB, the sGC inhibitor 
significantly counteracts the action of BPA induced inhibition 
of duodenal and cardiac movements. Further, from the results 
it was observed that L-NAME, the NOS inhibitor, also blocks 
the action of BPA-induced inhibition of duodenal and cardiac 
movements. From the results it is suggested that the BPA 
inhibits the duodenal and cardiac movements by inducing the 
release of NO from NANC neurons innervating the duodenal 
smooth muscle and cardiac myocytes; and the NO in turn 
produces the relaxation of muscle through guanylyl cyclase 
mediated signal pathway (Fig.8). 
 
 
Figure 8: Probable mechanism of action of BPA in smooth and cardiac 
muscle relaxation. 
V. CONCLUSION 
From the results it is concluded that BPA inhibits the duodenal 
and cardiac movement presumably by inducing the relaxation 
of smooth muscle and cardiac muscle through nitric oxide-
mediated guanylyl cyclase signal pathway. 
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